La Dra. Virginie es especialista en la identificación de biomarcadores de “overdiagnosis” y medicina personalizada en cáncer de próstata.

La invitación es para el miércoles 8 de junio a las 11 hs., en la Sala de Seminarios del IHEM (PB).

 The aim of Dr Firlej Lab is to investigate biomarkers of lethal prostate cancer using high-throughput microarray technologies (PAIR Prostate), to validate new prostate cancer treatments, to find molecular pathways involved in resistance on preclinical models, to study regulations of cancer cell proliferation and invasion by Heparin-affin regulatory growth factor (HARP) and to determine hormonal profiles of prostate cancer patients.